CN101417057B - 一种治疗风湿性心脏病的中药汤剂 - Google Patents
一种治疗风湿性心脏病的中药汤剂 Download PDFInfo
- Publication number
- CN101417057B CN101417057B CN2008102381483A CN200810238148A CN101417057B CN 101417057 B CN101417057 B CN 101417057B CN 2008102381483 A CN2008102381483 A CN 2008102381483A CN 200810238148 A CN200810238148 A CN 200810238148A CN 101417057 B CN101417057 B CN 101417057B
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- chinese medicine
- radix
- medicine decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 208000004124 rheumatic heart disease Diseases 0.000 title claims abstract description 27
- 229940079593 drug Drugs 0.000 claims abstract description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 3
- 230000004217 heart function Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 210000003709 heart valve Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000020128 Mitral stenosis Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 208000006887 mitral valve stenosis Diseases 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010027727 Mitral valve incompetence Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 208000005907 mitral valve insufficiency Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229940093252 sorbitrate Drugs 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗风湿性心脏病的中药汤剂，属中药领域。它是由下述重量的原料药制成：黄芪15-25克，白术15-25克，益母草15-25克，茯苓15-25克，白芍10-20克，半夏10-20克，丹参10-20克，川芎5-15克，赤芍5-15克，当归5-15克，桃仁5-15克，桂枝5-10克和甘草5-10克。该种治疗风湿性心脏病的中药汤剂，可缓解症状，控制病程进展，修复瓣膜内膜损伤，营养心肌，提高心功能的作用。
Description
技术领域
本发明涉及一种治疗心脏病的中药，属中药领域。
背景技术
风湿性心脏病简称“风心病”，是指由于风湿热活动，累及心脏瓣膜而造成的心脏病变。其实质系指湿性心脏病炎在心脏瓣膜上留下疤痕所造成的后遗病，使瓣膜狭窄与关闭不全，风心病是我国最常见的心脏病，在成人心血管疾病中，本病约占40％，多数病人为20至40岁的青壮年，女性稍多。患病初期常常无明显症状，后期则表现为心慌气短、乏力、咳嗽、肢体水肿、咳粉红色泡沫痰，直至心力衰竭而死亡。有的则表现为动脉栓塞以及脑梗塞而死亡。典型二尖瓣采用手术治疗风心病并非十全十美之法，原因是置换一个瓣膜，并不能抵御其它瓣膜不再受侵害。只有从根本上消除导致心脏瓣膜病变的病因，使心脏瓣膜免于再受致病菌的侵犯，才是治疗上策及彻底治愈的保证。
发明内容
本发明的目的在于克服现有技术存在的不足，而提供一种治疗风湿性心脏病的中药汤剂，针对风湿性心脏病辨证施治，有显著疗效。
本发明解决问题所采取的技术方案是：
一种治疗风湿性心脏病的中药汤剂，其特征在于，它是由下述重量的原料药制成：黄芪15-25克，白术15-25克，益母草15-25克，茯苓15-25克，白芍10-20克，半夏10-20克，丹参10-20克，川芎5-15克，赤芍5-15克，当归5-15克，桃仁5-15克，桂枝5-10克和甘草5-10克。
本发明进一步的技术方案是：
一种治疗风湿性心脏病的中药汤剂，其特征在于，它是由下述重量的原料药制成：黄芪20克，白术20克，益母草20克，茯苓20克，白芍15克， 半夏15克，丹参15克，川芎10克，赤芍10克，当归10克，桃仁10克，桂枝6克和甘草6克。
本发明所述的治疗风湿性心脏病的中药汤剂，其配制及服用方法是：
将原料药混合入砂锅内，加水500毫升泡透，先武火煎沸，再以文火煎半小时，滤出药液；药渣内加水适量再煎半小时，滤出药液；两次药液混合、凉透即成。一日两次，每次250毫升，分别于早饭前半小时，晚饭后两小时服用，两周一疗程。
本发明所述的治疗风湿性心脏病的中药汤剂，各原料药的作用有：
黄芪：性温，味甘。补气升阳，益卫固表、托毒生肌、利水退肿。
白术：苦甘，温。入脾、胃经。补脾，益胃，燥湿，和中，安胎。
益母草：辛苦，凉。活血，祛瘀，调经，消水。
茯苓：渗湿利水，益脾和胃，宁心安神。治小便不利，水肿胀满，痰饮咳逆，呕哕，泄泻，遗精，淋浊，惊悸，健忘。
白芍：苦酸，凉。入肝、脾经。养血柔肝，缓中止痛，敛阴收汗。
半夏：燥湿经痰，降逆止呕，消痞散结。治湿痰冷饮，呕吐反胃，痰厥头痛，头晕不眠。
丹参：苦，微寒；归心、肝经。降而行血，善入血分，能通经脉、化淤滞、清心火、凉血热，安神志、除悸烦，常用于胸痹心痛，月经部调、疮疡肿痛，失眠及淤血肿痛等症。
川芎：味辛，行气开郁，法风燥湿，活血止痛。
赤芍：苦，微寒。归肝经。清热凉血，散瘀止痛。
当归：甘辛，温。入心、肝、脾经。补血和血，调经止痛，润燥滑肠。
桃仁：活血祛瘀，润肠通便。用于经闭，痛经，癥瘕痞块，跌扑损伤，肠燥便秘。
桂枝：辛甘，温。入膀胱、心、肺经。发汗解肌，温经通脉。
甘草：补脾益气，滋咳润肺，缓急解毒，调和百药。甘草剂有抗炎和抗变态反映的功能；甘草次酸有去氧皮质酮类作用，对慢性肾上腺皮质功能减退有良好功效；甘草的黄酮具有消炎、解痉和抗酸作用。
西医认为风湿性心脏病是湿性心脏病炎在心脏瓣膜上留下疤痕所造成的后遗病，使瓣膜狭窄与关闭不全。中医学认为风湿性心脏病多属于“怔忡”、“喘证”、“水肿”、“心痹”等范畴，其病机主要是风寒湿邪内侵，久而化热或风湿热邪直犯，内舍于心，乃致心脉痹阻，血脉不畅，血行失度。针对本病的病因病机，应用中医中药利湿除痰，活血化瘀，补血养心，益气安神，修复受损的心脏瓣膜才能达到标本兼治的效果。
本发明所述的治疗风湿性心脏病的中药汤剂，可缓解症状，控制病程进展，修复瓣膜内膜损伤，营养心肌，提高心功能的作用。
本发明所述的治疗风湿性心脏病的中药汤剂，临床效果显著，已治疗43例患者，有效率84％。
典型病例有：
病例一，赵某，女，56岁。患风心病15年，二尖瓣狭窄中度，面部浮肿，口唇发青，心慌、劳累后加重，靠长期服用地高辛、双氢克尿塞等西药维持治疗，病情时好时坏。服用本发明中药汤剂治疗两个疗程后，心慌、闷气、乏力等症状明显好转，水肿消失。连续治疗四个疗程，临床症状消失，轻度活动后无不良症状出现，患者已能正常上班工作，至今没有复发。
病例二，姜某，女，48岁。半年来出现心慌气短，胸闷乏力，心律不齐，早搏等症状，做心脏彩超检查为风心病，二尖瓣狭窄(轻)，二尖瓣关闭不全，服用西药治疗，效果不理想，病情有发展趋势。她听从了中医的建议改用中药治疗。于是在服用本发明中药汤剂三个疗程后，病情完全缓解，至今没复发，能从事其工作和家务劳动。
病例三，隋某，女，63岁。近几年来常感觉手脚发冷，浑身出虚汗，疲劳乏力，稍微累一些就觉的心慌闷气，检查确诊为风湿性心脏病，二尖瓣狭窄(中度)，医生说不适合做手术，经常服用消心痛，安茶碱，心得安等药，基本上还可以做家务及轻体力劳动，但随着年龄增加，病情越来越重，行走困难，走几百米路就喘气，倦怠乏力。服用本发明中药汤剂治疗三个疗程后，小腿浮肿有些减退，可以下地走1里左右，继续服用2个疗程后，基本康复，生活自理，可做轻微家务劳动。
具体实施方式
实施例1
一种治疗风湿性心脏病的中药汤剂，它是由下述重量的原料药制成：黄芪15克，白术15克，益母草15克，茯苓15克，白芍10克，半夏20克，丹参20克，川芎15克，赤芍15克，当归5克，桃仁5克，桂枝10克和甘草10克。
其配制及服用方法是：
将原料药混合入砂锅内，加水500毫升泡透，先武火煎沸，再以文火煎半小时，滤出药液；药渣内加水适量再煎半小时，滤出药液；两次药液混合、凉透即成。一日两次，每次250毫升，分别于早饭前半小时，晚饭后两小时服用，两周一疗程。
实施例2
一种治疗风湿性心脏病的中药汤剂，它是由下述重量的原料药制成：黄芪25克，白术25克，益母草25克，茯苓25克，白芍20克，半夏10克，丹参10克，川芎5克，赤芍5克，当归15克，桃仁15克，桂枝5克和甘草5克。
其配制及服用方法同实施例1。
实施例3
一种治疗风湿性心脏病的中药汤剂，它是由下述重量的原料药制成：黄芪12克，白术15克，益母草15克，茯苓18克，白芍12克，半夏20克，丹参15克，川芎15克，赤芍5克，当归12克，桃仁8克，桂枝10克和甘草10克。
其配制及服用方法同实施例1。
实施例4
一种治疗风湿性心脏病的中药汤剂，它是由下述重量的原料药制成：黄芪20克，白术20克，益母草20克，茯苓20克，白芍15克，半夏15克，丹参15克，川芎10克，赤芍10克，当归10克，桃仁10克，桂枝6克和甘草6克。
其配制及服用方法同实施例1。
Claims (2)
1.一种治疗风湿性心脏病的中药汤剂，其特征在于，它是由下述重量的原料药制成：黄芪15-25克，白术15-25克，益母草15-25克，茯苓15-25克，白芍10-20克，半夏10-20克，丹参10-20克，川芎5-15克，赤芍5-15克，当归5-15克，桃仁5-15克，桂枝5-10克和甘草5-10克。
2.根据权利要求1所述的一种治疗风湿性心脏病的中药汤剂，其特征在于，它是由下述重量的原料药制成：黄芪20克，白术20克，益母草20克，茯苓20克，白芍15克，半夏15克，丹参15克，川芎10克，赤芍10克，当归10克，桃仁10克，桂枝6克和甘草6克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102381483A CN101417057B (zh) | 2008-12-09 | 2008-12-09 | 一种治疗风湿性心脏病的中药汤剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102381483A CN101417057B (zh) | 2008-12-09 | 2008-12-09 | 一种治疗风湿性心脏病的中药汤剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101417057A CN101417057A (zh) | 2009-04-29 |
| CN101417057B true CN101417057B (zh) | 2011-03-23 |
Family
ID=40628183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008102381483A Expired - Fee Related CN101417057B (zh) | 2008-12-09 | 2008-12-09 | 一种治疗风湿性心脏病的中药汤剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101417057B (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189786A (zh) * | 2014-09-28 | 2014-12-10 | 袁国防 | 一种治疗风湿性心脏病的中药 |
| CN104352855A (zh) * | 2014-11-04 | 2015-02-18 | 赵国忠 | 风心病通阳活血化瘀制剂及制备方法 |
| CN104645096A (zh) * | 2015-01-22 | 2015-05-27 | 李红星 | 一种用于治疗风湿性心脏病的中药组合物及其制备方法 |
| CN104667129B (zh) * | 2015-03-17 | 2018-07-24 | 山东省立医院 | 一种治疗风湿性心脏病的药物 |
| CN104825911A (zh) * | 2015-06-04 | 2015-08-12 | 王星月 | 一种治疗风湿性心脏病的中药 |
| CN104825787A (zh) * | 2015-06-04 | 2015-08-12 | 王星月 | 一种治疗风湿性心脏病的中药组合物 |
| CN107050155A (zh) * | 2017-05-11 | 2017-08-18 | 侯芳 | 一种治疗心脏病的中药 |
| CN107529439A (zh) * | 2017-09-30 | 2018-01-02 | 徐建业 | 一种治疗风湿性心脏病的中药丸剂及其制备方法 |
| CN107823590A (zh) * | 2017-11-15 | 2018-03-23 | 徐建业 | 一种治疗风湿性心脏病的中药胶囊及其制备方法 |
| CN109453311A (zh) * | 2018-11-14 | 2019-03-12 | 朱宗华 | 一种用于慢性心脏病缓解期的中药方剂 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1234264A (zh) * | 1999-04-08 | 1999-11-10 | 梁彦东 | 一种治疗慢性风湿性心脏病的中药组合物 |
| CN101002925A (zh) * | 2006-12-28 | 2007-07-25 | 龚文君 | 一种治疗呕逆不食型风湿性心脏病的内服中药 |
| CN101002875A (zh) * | 2006-12-28 | 2007-07-25 | 龚文君 | 一种治疗脾气虚弱型风湿性心脏病的内服中药 |
| CN101028351A (zh) * | 2006-12-28 | 2007-09-05 | 龚文君 | 一种治疗脾虚不运型风湿性心脏病的内服中药 |
-
2008
- 2008-12-09 CN CN2008102381483A patent/CN101417057B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1234264A (zh) * | 1999-04-08 | 1999-11-10 | 梁彦东 | 一种治疗慢性风湿性心脏病的中药组合物 |
| CN101002925A (zh) * | 2006-12-28 | 2007-07-25 | 龚文君 | 一种治疗呕逆不食型风湿性心脏病的内服中药 |
| CN101002875A (zh) * | 2006-12-28 | 2007-07-25 | 龚文君 | 一种治疗脾气虚弱型风湿性心脏病的内服中药 |
| CN101028351A (zh) * | 2006-12-28 | 2007-09-05 | 龚文君 | 一种治疗脾虚不运型风湿性心脏病的内服中药 |
Non-Patent Citations (1)
| Title |
|---|
| 李朝仁等.风湿性心脏病制验3则.《中医药导报》.2008,第14卷(第10期),第60页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101417057A (zh) | 2009-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101417057B (zh) | 一种治疗风湿性心脏病的中药汤剂 | |
| CN103341064B (zh) | 一种治疗癃闭的中药组合物 | |
| CN104758852A (zh) | 一种治疗高血压的中药组合物 | |
| CN102940785B (zh) | 一种治疗眩晕症的中药组合物 | |
| CN104800634A (zh) | 一种治疗高血压的药物及其制备方法 | |
| CN101204481A (zh) | 一种治疗慢性肾炎的中药 | |
| CN105250890A (zh) | 一种治疗高脂血症中药 | |
| CN104107398A (zh) | 一种治疗风湿性心脏病的中药组合物 | |
| CN103599404A (zh) | 一种治疗颈椎病的中药汤剂 | |
| CN101428114B (zh) | 一种治疗慢性乙肝、肝硬化和肝腹水的药物 | |
| CN102824610A (zh) | 一种治疗慢性胆囊炎的药物 | |
| CN103394030B (zh) | 一种治疗肝郁脾虚的中药组合物 | |
| CN105106802A (zh) | 一种治疗周围性面瘫的中药组合物 | |
| CN104189786A (zh) | 一种治疗风湿性心脏病的中药 | |
| CN104645078A (zh) | 一种治疗偏头痛的中药组合物 | |
| CN104383268A (zh) | 一种治疗高血压的中药组合物 | |
| CN104740142A (zh) | 一种治疗坐骨神经痛的中药 | |
| CN102441133A (zh) | 一种治疗股骨头坏死的中药 | |
| CN102349986B (zh) | 一种治疗更年期综合症的中药 | |
| CN101708266B (zh) | 一种内服治疗骨质疏松的中药汤剂 | |
| CN106139015A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
| CN101721518A (zh) | 一种治疗老年性便秘的中药 | |
| CN105362914A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN104667129B (zh) | 一种治疗风湿性心脏病的药物 | |
| CN103463397A (zh) | 一种治疗肾阴虚的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHAO YUJIE WANG XIUYUN Owner name: CUI XIAONING Free format text: FORMER OWNER: YIN GUOBIN Effective date: 20101217 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Cui Xiaoning Inventor after: Zhao Yujie Inventor after: Wang Xiuyun Inventor before: Yin Guobin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YIN GUOBIN TO: CUI XIAONING ZHAO YUJIE WANG XIUYUN Free format text: CORRECT: ADDRESS; FROM: 265700 (INSIDE NO. 1, 724, LUTOU STREET) LUTOU HOSPITAL, LUTOU TOWN, LONGKOU CITY, SHANDONG PROVINCE TO: 252000 LIAOCHENG PEOPLE S HOSPITAL, NO. 67, DONGCHANG WEST ROAD, LIAOCHENG CITY, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20101217 Address after: 252000 Shandong city of Liaocheng Province Dongchang Road No. 67 Liaocheng People's Hospital Applicant after: Cui Xiaoning Co-applicant after: Zhao Yujie Co-applicant after: Wang Xiuyun Address before: 265700 Shandong province Longkou City Province Lu tou town head hospital (1 724 inside the reed Street) Applicant before: Yin Guobin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110323 Termination date: 20111209 |